COVID-19:吉利德remdesivir药物在大规模试验中仅具有适度的获益。股价下跌

flu, Pharmaceutical

COVID-19:Actemra和remdecivir联合测试:Roche于6月开始注册

flu, Pharmaceutical

COVID-19:什么是电晕对策“日本模式”?:戴夫·斯佩特

flu, Medical care, monitor, medical service

COVID-19:出现蓝色冲动:对Aozora市中心的赞赏和尊重

flu, Airplane, Statistics, Aviation, medical service

COVID-19:Shimadzu实现唾液的PCR检测:使用新的检测试剂盒即可

flu, Sensor, Pharmaceutical

Posts navigation